Tag: Viatris

Dave Bloom RE neffy denial by the FDA

Why the FDA Changed Course at the Last Minute to Deny...

Did the FDA kowtow to corporate greed?
neffy®

FDA Denies Approval of Needle-Free Alternative to Epinephrine Auto-injectors

The rejection was unexpected based on feedback from the FDA's expert panel in June.
Man Holding Auto-Injector

State Legislation Would Make Epinephrine Auto-Injectors More Affordable

Would cap out-of-pocket expenses to $60 per two-pack for insured and uninsured.
EpiPens

Viatris Responds Regarding EpiPen Family of Auto-Injectors in Light of Spectrum...

The EpiPen family of auto-injectors is NOT affected by the recall according to Viatris.
EpiPen Shortage

The Netherlands is Experiencing an EpiPen Shortage. Does This Portend a...

There's no need for panic, just vigilance.
Ben and EpiPens

Attorneys the Big Winners in Mylan $264 Million EpiPen Price Gouging...

Settlement for consumers pales in comparison to the compensation Mylan execs received while the scheme was ongoing.
Ben and EpiPens

Viatris — Formerly Mylan — Agrees to $264 Million Settlement to...

Company does not admit to wrongdoing in settlement.
Ben and EpiPens

Who Benefits Most from Pfizer’s $345M EpiPen Price Gouging Settlement? Not...

One-third of the total award will go to the law firms that represented consumers in the suit.
Robert Coury

Exec Who Told the Food Allergy Community to F— Themselves Received...

Robert Coury is no stranger to huge bonuses despite public outcry.